KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.

KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.

Item
http://www.wikidata.org/entity/Q37395457
The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targetsThe role of lymphangiogenesis and angiogenesis in tumor metastasisClinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinomaKAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancerCalretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9.Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumoursClinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinomaKAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherinMetastasis suppressors in breast cancers: mechanistic insights and clinical potentialOverexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer.The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model.
P2860

KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.

Item
http://www.wikidata.org/entity/Q37395457
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@en
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@nl
type
label
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@en
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@nl
prefLabel
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@en
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
@en
P2093
P304
P31
P356
P433
P478
P577
P698